Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy

Affiliations

¹ Department of Dermatology, University of Naples Federico II, Napoli, Italy.
² Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
³ Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.

Case Reports

Matteo Megna et al. Contact Dermatitis. 2019 Dec.

. 2019 Dec;81(6):451-454.

doi: 10.1111/cod.13358. Epub 2019 Jul 31.

¹ Department of Dermatology, University of Naples Federico II, Napoli, Italy.
² Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso, Italy.
³ Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.

No abstract available

Keywords: apremilast; case report; paracetamol; symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).

References

1. Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis. 2004;51:297-310.
1. Kawashima H, Okubo Y, Okubo Y, Hoshika A. A new proposal for a clinical-oriented subclassification of baboon syndrome and a review of baboon syndrome. Asian Pac J Allergy Immunol. 2011;29:150-160.
1. Magnolo N, Metze D, Ständer S. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). J Dtsch Dermatol Ges. 2017;15:657-659.
1. Weiss D, Kinaciyan T. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid. JAAD Case Rep. 2018;5:89-90.
1. Caralli ME, Seoane Rodríguez M, Rojas Pérez-Ezquerra P, Pelta Fernández R, de Barrio Fernández M. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) caused by etoricoxib. J Investig Allergol Clin Immunol. 2016;26:128-129.